Clinical Trials Logo

Foetuses Infection clinical trials

View clinical trials related to Foetuses Infection.

Filter by:
  • None
  • Page 1

NCT ID: NCT01651585 Completed - Foetuses Infection Clinical Trials

In Utero Treatment of Cytomegalovirus congénitale Infection With Valacyclovir

CYMEVAL2
Start date: July 2011
Phase: Phase 4
Study type: Interventional

The infection with cytomegalovirus (CMV) is the first cause of congenital neurological handicap of infectious origin. It is probable that the néonatale viral load is correlated with becoming of infected new-born babies. Among the active antiviral treatments against CMV, valacyclovir is the only whose fœtal and maternal tolerance was evaluated during the pregnancy. Its harmlessness and its aptitude to decrease the CMV viral load justify to evaluate it in a study. Decrease the fœtal viral load could make possible to decrease symptomatology néonatale in a group of infected fœtuses.